Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 9, 2008, Pages 3478-3483

  Sowers, MaryFran R ^a,b,d   Eyvazzadeh, Aimee D ^b   McConnell, Daniel ^a   Yosef, Matheos ^a   Jannausch, Mary L ^a   Zhang, Daowen ^c   Harlow, Sioban ^a   Randolph Jr , John F ^b  

^a UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; INHIBIN B; MUELLERIAN INHIBITING FACTOR;

ADULT; AGE; AGING; ARTICLE; CLIMACTERIUM; FEMALE; FOLLICULAR PHASE; HORMONE DETERMINATION; HUMAN; HUMAN TISSUE; MENSTRUAL CYCLE; OVARY FOLLICLE; PREMENOPAUSE; PRIORITY JOURNAL;

EID: 51649114309     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-0567     Document Type: Article

References (34)

1. Vigier B, Picard JY, Tran D, Legeai L, Josso N 1984 Production of anti-Müllerian hormone: another homology between Sertoli and granulosa cells. Endocrinology 114:1315-1320
2. Durlinger AL, Kramer P, Karels B, de Jong FH, Uilenbroek JT, Grootegoed A, Themmen AP 1999 Control of primordial follicle recruitment by anti-Müllerian hormone in the mouse ovary. Endocrinology 140:5789-5796
3. Durlinger AL, Gruijters MJ, Kramer P, Karels B, Kumar TR, Matzuk MM, Rose UM, de Jong FH, Uilenbroek JT, Grootegoed JA, Themmen AP 2001 Anti-Mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology 142:4891-4899
4. te Velde ER, Pearson PL 2002 The variability of female reproductive ageing. Hum Reprod Update 8:141-154
5. Vale W, Hsueh A, Rivier C, Yu J 1990 The inhibin/activin family of growth factors. In: Sporn MA, Roberts AB, eds. Peptide growth factors and their receptors: handbook of experimental pharmacology. New York: Springer-Verlag; 211-248
6. Pierson TM, Wang Y, DeMayo FJ, Matzuk MM, Tsai SY, OMalley BW 2000 Regulable expression of inhibin A in wild-type and inhibin α null mice. Mol Endocrinol 14:1075-1085
7. Welt C, Sidis Y, Keutmann H, Schneyer A 2002 Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium. Exp Biol Med 227:724-752
8. Welt CK 2004 Regulation and function of inhibins in the normal menstrual cycle. Semin Reprod Med 22:187-193
9. McLachlan RI, Robertson DM, Healy DL, Burger HG, de Kretser DM 1987 Circulating immunoreactive inhibin levels during the normal human menstrual cycle. J Clin Endocrinol Metab 65:954-961
10. Seifer DB, MacLaughlin DT, Christian BP, Feng B, Shelden RM 2002 Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril 77:468-471
11. van Rooij IA, Broekmans FJ, te Velde ER, Fauser BC, Bancsi LF, de Jong FH, Themmen AP 2002 Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod 17:3065-3071
12. Hazout A, Bouchard P, Seifer DB, Aussage P, Junca AM, Cohen-Bacrie P 2004 Serum antimullerian hormone/mullerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol. Fertil Steril 82:1323-1329
13. van Rooij IA, Tonkelaar I, Broekmans FJ, Looman CW, Scheffer GJ, de Jong FH, Themmen AP, te Velde ER 2004 Anti-mullerian hormone is a promising predictor for the occurrence of the menopausal transition. Menopause 11:601-606
14. Ficicioglu C, Kutlu T, Baglam E, Bakacak Z 2006 Early follicular antimullerian hormone as an indicator of ovarian reserve. Fertil Steril 85:592-596
15. Ebner T, Sommergruber M, Moser M, Shebl O, Schreier-Lechner E, Tews G 2006 Basal level of anti-Mullerian hormone is associated with oocyte quality in stimulated cycles. Hum Reprod 21:2022-2026
16. Danforth DR, Arbogast LK, Mroueh J, Kim MH, Kennard EA, Seifer DB, Friedman CI 1998 Dimeric inhibin: a direct marker of ovarian aging. Fertil Steril 70:119-123
17. Welt CK, McNicholl DJ, Taylor AE, Hall JE 1999 Female reproductive aging is marked by decreased secretion of dimeric inhibin. J Clin Endocrinol Metab 84:105-111
18. Seifer DB, Scott Jr RT, Bergh PA, Abrogast LK, Friedman CI, Mack CK, Danforth DR 1999 Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before a rise in day 3 follicle-stimulating hormone. Fertil Steril 72:63-65
19. Freeman EW, Sammel MD, Gracia CR, Kapoor S, Lin H, Liu L, Nelson DB 2005 Follicular phase hormone levels and menstrual bleeding status in the approach to menopause. Fertil Steril 83:383-392
20. Sowers MF, Kshirsagar A, Crutchfield MM, Updike S 1992 Joint influence of fat and lean body composition compartments on femoral bone mineral density in premenopausal women. Am J Epidemiol 136:257-265
21. Sowers M, Willing M, Burns T, Deschenes S, Hollis B, Crutchfield M, Jannausch M 1999 Genetic markers, bone mineral density, and serum osteocalcin levels. J Bone Miner Res 14:1411-1419
22. Thiebaut R, Jacqmin-Gadda H 2004 Mixed models for longitudinal left-censored repeated measures. Comput Methods Programs Biomed 74:255-260
23. de Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC 2002 Antimüllerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril 77:357-362
24. te Velde ER 1998 Ovarian ageing and postponement of childbearing. Maturitas 30:103-104
25. Faddy MJ, Gosden RG, Gougeon A, Richardson SJ, Nelson JF 1992 Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod 7:1342-1346
26. Faddy MJ, Gosden RG 1996 A model conforming the decline in follicle numbers to the age of menopause in women. Hum Reprod 11:1484-1486
27. Richardson SJ, Senikas V, Nelson JF 1987 Follicular depletion during the menopausal transition: evidence for accelerated and ultimate exhaustion. J Clin Endocrinol Metab 65:1231-1237
28. te Velde ER, Scheffer GJ, Dorland M, Broekmans FJ, Fauser BC 1998 Developmental and endocrine aspects of normal ovarian aging. Mol Cell Endocrinol 145:67-73
29. van Rooij IA, Broekmans FJ, Scheffer GJ, Looman CW, Habbema JD, de Jong FH, Fauser BJ, Themmen AP, te Velde ER 2005 Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril 83:979-987
30. Soules MR, Battaglia DE, Klein NA 1998 Inhibin and reproductive aging in women. Maturitas 30:193-204
31. Taffe JR, Dennerstein L 2002 Menstrual patterns leading to the final menstrual period. Menopause 9:32-40
32. Burger HG, Cahir N, Robertson DM, Groome NP, Dudley E, Green A, Dennerstein L 1998 Serum inhibins A and B fall differentially as FSH rises in perimenopausal women. Clin Endocrinol (Oxf) 48:809-813
33. Magoffin DA, Jakimiuk AJ 1997 Inhibin A, inhibin B and activin A in the follicular fluid of regularly cycling women. Hum Reprod 12:1714-1719
34. Lockwood GM, Muttukrishna S, Goome NP, Matthews DR, Ledger WL 1998 Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle. J Clin Endocrinol Metab 83:1730-1735